GGrantIndex
Sort

64,565 grants matching drug discovery

CCI Phase I: NSF Center for Genomically Encoded Materials (C-GEM)

$826,506
Alanna Schepartz · University Of California-Berkeley · · FY2019 · MPS

A Preclinical Program for Targeting Mycobacterium tuberculosis KasA

$826,401
Joel Stephen Freundlich · Rbhs-New Jersey Medical School · R01 · FY2021 · AI

Structural Biology Core

$826,349
Karson Putt · Indiana University Indianapolis · U54 · FY2023 · AG

Depot formulation of a D-peptide HIV entry inhibitor

$826,272
Alan L Mueller · Navigen, Inc. · R01 · FY2017 · AI

HTS for copper-activated inhibitors against MRSA

$826,146
Frank Wolschendorf · University Of Alabama At Birmingham · R01 · FY2016 · AI

Targeting S-adenosylmethionine decarboxylase for HAT drug discovery

$826,050
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2014 · AI

High Resolution Characterization of Bacterial Epigenomes and Microbiome

$825,990
Gang Fang · Icahn School Of Medicine At Mount Sinai · R35 · FY2022 · GM

High Resolution Characterization of Bacterial Epigenomes and Microbiome

$825,990
Gang Fang · Icahn School Of Medicine At Mount Sinai · R35 · FY2023 · GM

High Resolution Characterization of Bacterial Epigenomes and Microbiome

$825,990
Gang Fang · Icahn School Of Medicine At Mount Sinai · R35 · FY2025 · GM

High Resolution Characterization of Bacterial Epigenomes and Microbiome

$825,990
Gang Fang · Icahn School Of Medicine At Mount Sinai · R35 · FY2024 · GM

HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER

$825,985
Haian Fu · Emory University · U01 · FY2012 · CA

High Throughput Protein-Protein Interaction Interrogation in Cancer

$825,985
Haian Fu · Emory University · U01 · FY2012 · CA

Co-Abuse Cannabis and Tobacco

$825,970
Jenny L. Wiley · Research Triangle Institute · R33 · FY2019 · DA

Control of Tsetse Fly Transmitted Diseases in Kenya

$825,920
Serap Aksoy · Yale University · U01 · FY2019 · AI

Function and Structure Adaptations in Forebrain Development

$825,800
Pat R Levitt · Children'S Hospital Of Los Angeles · R01 · FY2019 · MH

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers

$825,656
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers

$825,543
Steven A. Carr · Broad Institute, Inc. · U24 · FY2016 · CA

ANTICANCER DRUGS ACTIVE AGAINST CELL CYCLE AND SIGNAL PA

$825,333
University Of Arizona · U19 · FY2000 · CA

High throughput laboratory X-ray illumination system for protein crystallography and screening

$825,315
Wenbing Yun · Sigray, Inc. · R44 · FY2016 · GM

Critical angle reflection imaging for label-free quantification of molecular interactions

$825,247
Nguyen Ly · Biosensing Instrument, Inc. · R42 · FY2022 · GM

Development of in vivo probes to study the function of TRIP8b in cognition

$825,034
Dane M Chetkovich · Vanderbilt University Medical Center · R56 · FY2023 · MH

OXGR1 in Renal Intercalated Cells, Salt Transport and Diuretic Efficacy

$825,023
Paul A Welling · Johns Hopkins University · R01 · FY2020 · DK

Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs

$825,019
Brian Tsuji · State University Of New York At Buffalo · R01 · FY2014 · AI

Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research

$824,998
Lee E Goldstein · Boston University Medical Campus · R01 · FY2023 · AG

IDENTIFYING GENETIC, TRANSCRIPTIONAL, AND MICROENVIRONMENT DRIVERS OF LETHAL PROSTATE CANCER FOR PATIENT STRATIFICATION, DISEASE TRACKING, AND DRUG TARGET DISCOVERY.

$824,895
University Of Melbourne · · FY2021 · Defense Health Agency